DYADIC INTERNATIONAL INC Employee-related Liabilities, Current
DYADIC INTERNATIONAL INC (DYAI) had Employee-related Liabilities, Current of $362.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Employee-related Liabilities, Current $362.83K.
- 2026-03-31: Employee-related Liabilities, Current $237.17K.
- 2025-12-31: Employee-related Liabilities, Current $395.46K.
- 2025-09-30: Employee-related Liabilities, Current $486.98K.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $362.83K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $237.17K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $395.46K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $486.98K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $349.19K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $225.45K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $496.90K 10-K · filed 2026-03-25 |
| 2024-09-30 | $442.60K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $330.18K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $400.97K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $561.72K 10-K · filed 2025-03-26 |
| 2023-09-30 | $429.82K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $322.44K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $187.03K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $580.26K 10-K · filed 2024-03-28 |
| 2022-09-30 | $258.13K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $309.20K 10-Q · filed 2022-08-10 |
| 2022-01-01 | $200.26M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $405.76K 10-K · filed 2023-03-29 |
| 2021-09-30 | $410.78K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $276.11K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $175.21K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $447.88K 10-K · filed 2022-03-29 |
| 2020-09-30 | $396.57K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $285.13K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $162.31K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $474.39K 10-K · filed 2021-03-30 |
| 2019-09-30 | $353.55K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $258.62K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $166.17K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $268.29K 10-K · filed 2020-03-30 |
| 2017-12-31 | $83.67K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |